Presentation TCT 2017 The Worst Misinterpretations Ive Seen in Observational Research Studies: How to Spot Them, How to Avoid Them Presenter: Robert A. Harrington, Sanjay Kaul October 30, 2017
Presentation TCT 2017 Featured Lecture: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients : Complete 1-Year Outcomes from the SURTAVI Trial Presenter: Martin B. Leon, Patrick T. O'Gara, Nicolas M. Van Mieghem October 30, 2017
Presentation TCT 2017 Vessix RE-INFORCE Trial Update Presenter: Michael Böhm, Thomas F. Luscher, Michael A. Weber October 30, 2017
Presentation TCT 2017 MiStent and DESSOLVE III Outcomes: Are the Stent and Clinical Trial Results Unique? Presenter: Ioannis Iakovou, Gert Richardt, Robert J. de Winter October 30, 2017
Presentation TCT 2017 Topic 4: At the Cusp of Diminishing Returns for CV Therapies - Personalized Approaches and New Frontiers Presenter: Robert A. Byrne, Gregg W. Stone, Robert A. Harrington October 30, 2017
Presentation TCT 2017 Catheter-Based Ultrasound Renal Denervation: RADIANCE Trial Update Presenter: Michael Böhm, Thomas F. Luscher, Laura Mauri October 30, 2017
Presentation TCT 2017 Amulet: Data Synthesis and Ongoing Trials Presenter: William A. Gray, Vivek Y. Reddy, Fabian Nietlispach October 30, 2017
Presentation TCT 2017 Clinical Trials Using RAPID: Some POC Thoughts Presenter: Schuyler Jones, Hiroyoshi Yokoi, Theodore Heise October 30, 2017
Presentation TCT 2017 KONAs WAVE IV Randomized Trial: Principal Results and Lessons Learned Presenter: Michael Böhm, Thomas F. Luscher, Melvin D. Lobo October 30, 2017
Presentation TCT 2017 Topic 3: Chronic Total Occlusion PCI - What Level of Evidence Is Required for Widespread Acceptance: Hard Endpoints vs QOL Measures Presenter: Robert A. Byrne, Gregg W. Stone, J. Aaron Grantham October 30, 2017
Presentation TCT 2017 WATCHMAN: Data Synthesis and Ongoing Trials Presenter: William A. Gray, Vivek Y. Reddy October 30, 2017
Presentation TCT 2017 Do the PIONEER and RE-DUAL Results Alter LAA Closure Decisions? Presenter: William A. Gray, Vivek Y. Reddy, C. Michael Gibson October 30, 2017
Presentation TCT 2017 Topic 2: Outcomes Without a Clear Mechanism (Radial Mortality Benefit, Aspirin/Ticagrelor Interaction, and More) Presenter: Robert A. Byrne, Gregg W. Stone, Robert A. Harrington October 30, 2017
Presentation TCT 2017 Perspectives on Current Trials in Renal Denervation: Evolution of Design, Endpoints, and Objectives Presenter: Michael Böhm, Thomas F. Luscher, Felix Mahfoud October 30, 2017
Presentation TCT 2017 Should the Improved Results With NOACs Compared to Warfarin Change LAA Closure Decisions? Presenter: William A. Gray, Vivek Y. Reddy, Kurt Huber October 30, 2017
Presentation TCT 2017 Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of Women Presenter: Wayne B. Batchelor, George A. Mensah, Roxana Mehran October 30, 2017
Presentation TCT 2017 Topic 1: How Should We Evaluate Technologies in Their Infancy? TAVR, Renal Denervation, BVS, LAA Closure, Mechanical Circulatory Support, and More Presenter: Robert A. Byrne, Gregg W. Stone, Aaron V. Kaplan October 30, 2017
Presentation TCT 2017 Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of African American/Latina Populations Presenter: Wayne B. Batchelor, George A. Mensah October 30, 2017
Presentation TCT 2017 Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: SCAI Presenter: Wayne B. Batchelor, George A. Mensah, Cindy L. Grines October 30, 2017
Presentation TCT 2017 Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: STS/AATS Presenter: Wayne B. Batchelor, George A. Mensah, Vinod H. Thourani October 30, 2017